What’s more, it was identified that 24-dehydrocholesterol reductase (DHCR24), a key regulator of synthesis and metabolism of cholesterol, was downregulated in vulnerable regions in AD patient brain [25, 31]. Here, DHCR24 is linked to Alzheimer disease.